INC Research is a diagnostics & research business based in the US. INC Research shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. INC Research employs 28,768 staff and has a trailing 12-month revenue of around $5.4 billion.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $42.78 |
|---|---|
| 52-week range | $22.89 - $52.23 |
| 50-day moving average | $42.40 |
| 200-day moving average | $38.65 |
| Wall St. target price | $42.50 |
| PE ratio | 61.0286 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.70 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $42.78 from 2023-09-20
| 1 week (2023-09-15) | 0.09% |
|---|---|
| 1 month (2023-08-22) | 0.64% |
| 3 months (2023-06-22) | 2.52% |
| 6 months (2023-03-22) | 26.42% |
| 1 year (2022-09-18) | N/A |
|---|---|
| 2 years (2021-09-22) | -55.10% |
| 3 years (2020-09-22) | 54.48 |
| 5 years (2018-09-21) | 49.1 |
Valuing INC Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INC Research's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $5.4 billion |
|---|---|
| Operating margin TTM | 6.33% |
| Gross profit TTM | $1.3 billion |
| Return on assets TTM | 2.63% |
| Return on equity TTM | 2.09% |
| Profit margin | 1.31% |
| Book value | $33.69 |
| Market Capitalization | $4.4 billion |
TTM: trailing 12 months
We're not expecting INC Research to pay a dividend over the next 12 months.
Over the last 12 months, INC Research's shares have ranged in value from as little as $22.8941 up to $52.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INC Research's is 1.5826. This would suggest that INC Research's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Syneos Health, Inc. , operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.